Clareo Health | Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institutes of Health Clinical Center (CC)
With
Duke University
Emory University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age and older
Stenotrophomonas maltophilia culture positive from blood or the following specified respiratory tract sites: sputum, tracheal aspirate, bronchoalveolar lavage and protected bronchial brush washings
Received either levofloxacin or TMP/SMX targeted therapy
Those patients that received empiric therapy with a consistent medication (for example, levofloxacin empirically in the levofloxacin targeted therapy cohort) were included
You may not be if
Received inconsistent empiric therapy (for example, levofloxacin empirically in the TMP/SMX targeted therapy cohort) will be excluded from analysis
